Mammoth Biosciences
Brief Description
Mammoth’s vision is to provide a CRISPR-based platform on which an infinite number of tests can be built by both ourselves and our partners - democratizing access to an endless variety of tests for bio sensing in healthcare, as well as across industries such as agriculture, manufacturing, forensics, and more.
Inventor
Jennifer Doudna
Tech Category
- Research Tools
- Medical Therapeutics
- Medical Devices
In the News
- Mammoth Biosciences Receives FDA Emergency Use Authorization for First CRISPR-based High-Throughput COVID-19 Test 1/24/22
- Bayer to Pay CRISPR-focused Mammoth Biosciences $40 Million for Gene Editing Research 1/10/22
- Mammoth Biosciences Raises $195 Million, Vaulting Its Crispr Tech to Unicorn Status 9/9/21
- Mammoth Biosciences Named to Fierce Medtech’s “Fierce 15” Companies of 2020 for Advancing Next Generation CRISPR Products in Diagnostics and Therapeutics 3/8/21
- Mammoth Biosciences Teams with Agilent to Deliver CRISPR-based Coronavirus Tests 1/28/21
- Mammoth Biosciences Secures Award to Develop CRISPR-based Diagnostics and Biosurveillance Platforms 1/14/21
- Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company 10/29/20
- Jennifer Doudna, Mammoth Biosciences Co-Founder, Wins 2020 Nobel Prize in Chemistry for CRISPR-Cas9 Genome Editing Breakthrough 10/7/20
- FDA Grants EUAs for Mammoth Biosciences Coronavirus Tests 9/1/20
- Mammoth Biosciences Further Strengthens IP Portfolio with Exclusive License to Novel Micro-Sized CRISPR Proteins 8/12/20
- Mammoth Biosciences Among Winners of NIH’s ‘Shark Tank’ for Covid-19 Tests 7/31/20
- Mammoth Biosciences Collaborates with GSK Consumer Healthcare to Develop COVID-19 Test Using CRISPR-Based Platform 5/20/20
- New CRISPR-Based COVID-19 Test Kit Can Diagnose Infection in Less Than an Hour 4/16/20
- Horizon Discovery, Mammoth Biosciences Sign Second CRISPR Tools Development Agreement 2/14/20
- Mammoth Biosciences Raises $45 Million to Build Next Generation CRISPR Products for Therapeutics and Diagnostics 1/30/20
- Over-the-Counter Cancer Tests? 12/19/19
- A medical diagnostics startup that wants to use CRISPR technology to detect diseases raised $23 million in venture funding 11/13/18
© 2022 Regents of the University of California. All Rights Reserved.